Vice President, Medical Affairs & Scientific Innovation
Conor Gallagher is Vice President of Medical Affairs and Scientific Innovation at Revance Inc.
In his Medical Affairs role, he oversees the Medical function for both Revance Aesthetics and Therapeutics franchise. Conor also leads the Scientific Innovation team which is Revance’s preclinical R&D function.
Regarded as a leading expert in the neurotoxins and aesthetics fields, he has published over 40 peer-reviewed papers in both the aesthetic and therapeutic neurotoxins fields and designed and ran numerous clinical trials.
Prior to joining Revance, Conor spent 12 years at Allergan Directing the neurotoxins differentiation strategy and then as Global Medical Director, Facial Aesthetics, where he had responsibility for their neuromodulator, dermal fillers and injectable lipolytic agent.
He holds a PhD in Neurophysiology from the University of Toronto where he also served as an adjunct professor of Anatomy. His Master of Science is in Anatomy. His postdoctoral studies focused on characterization of skin-derived stem cells.